Latest News and Press Releases

Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "Licensing Deals in Pharmaceuticals 2019-2025" report has been added to ResearchAndMarkets.com's offering.Licensing Deals in Pharmaceuticals provides...

Rockville, MD, Feb. 05, 2025 (GLOBE NEWSWIRE) -- In 2019, the net worth of the global primary hepatocytes market was around US$ 189.5 million. According to Fact.MR estimates this value is going to...

Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "U.S. Multiomics Market Size, Share & Trends Analysis Report by Product & Service (Instruments, Consumables), Type (Single-cell, Bulk),...

New York, NY, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM) will present its prestigious, historic annual awards at a virtual event on Wednesday, September 27, 2023....

If approved, will be first-of-a-kind biosimilar natalizumab in Europe, for use in all indications of reference biologic Positive CHMP opinion based on evidence from extensive analytical...

Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) biosimilar offers US patients reduced injection volume in citrate-free formulationAs one of the only adalimumab HCF biosimilars approved...

Dublin, March 29, 2023 (GLOBE NEWSWIRE) -- The "Lipidomic Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Offering, and End User" report has been added to ...

NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The Vilcek Foundation announces the recipients of the 2023 Vilcek Foundation Prizes. Awarded annually in the arts and sciences, the prizes recognize and...

Dublin, Jan. 14, 2022 (GLOBE NEWSWIRE) -- The "Global Big Pharma Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global Big Pharma...

VANCOUVER, British Columbia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV)(OTCQB:PRVCF)(FSE:18H), announces the...